UBX Insider Trading Activity and SEC Form 4 Filings
UBX insider trading summary
No open-market insider purchases or sales of Unity Biotechnology, Inc. (UBX) have been reported on SEC Form 4 in the past 12 months.
Latest UBX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Apr 2, 2025 | Lynne Marie Sullivan | CFO & Head of Corp. Dev. | Sell | $23K (21,867 @ $1.03) |
| Apr 2, 2025 | Anirvan Ghosh | Chief Executive Officer | Sell | $100K (96,797 @ $1.03) |
| Apr 2, 2025 | Alexander Hieu Nguyen | CLO and Head of Ops | Sell | $18K (17,852 @ $1.03) |
| Mar 27, 2025 | Alexander Hieu Nguyen | CLO and Head of Ops | Sell | $2K (1,954 @ $1.16) |
| Feb 4, 2025 | Alexander Hieu Nguyen | CLO and Head of Ops | Sell | $366 (164 @ $2.23) |
| Feb 4, 2025 | Lynne Marie Sullivan | CFO & Head of Corp. Dev. | Sell | $341 (153 @ $2.23) |
| Feb 4, 2025 | Anirvan Ghosh | Chief Executive Officer | Sell | $1K (642 @ $2.23) |
| Nov 4, 2024 | Lynne Marie Sullivan | CFO & Head of Corp. Dev. | Sell | $175 (136 @ $1.29) |
| Nov 4, 2024 | Alexander Hieu Nguyen | Chief Legal Officer | Sell | $192 (149 @ $1.29) |
| Nov 4, 2024 | Anirvan Ghosh | Chief Executive Officer | Sell | $557 (432 @ $1.29) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.